Population
27 obese patients with insulin-treated type 2 diabetes mellitus
Design
Cross-sectional
Authors
Loading...
Suggests adipose inflammation as potential driver of liver fat in T2DM; hypothesis-generating, requires prospective confirmation.
Pro-inflammatory changes in subcutaneous adipose tissue are associated with increased liver fat content in obese patients with insulin-treated T2DM, suggesting adipose inflammation may drive liver fat accumulation.
Jansen et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: